A study that revealed new findings about prostate cells may point to future strategies for treating aggressive and therapy-resistant forms of prostate cancer.
The study proved that the prostate basal cell layer contains adult stem cells which possess a unique gene expression profile resembling the deadliest form of prostate cancer. The research was led by The University of Texas MD Anderson Cancer Center with findings published...
Nearly 50 faculty members at The University of Texas MD Anderson Cancer Center were honored for their exceptional efforts in the fight against...
The University of Texas MD Anderson Cancer Center returns to Sarasota, Fla. March 5 for its signature Making Cancer History® Seminar. Renowned...
The University of Texas MD Anderson Cancer Center was awarded $14 million this week from the Cancer Prevention and Research Institute of Texas (CPRIT) for the recruitment of three cancer scientists. The awards include $12 million for recruitment of two senior researchers and $2 million for a first-time, tenure-track faculty member
The awards accounted for 54 percent of the $26 million CPRIT awarded this week for recruitment of...
Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current staging...
ONC201, an anti-cancer drug that triggers cell death in various tumor types, may have clinical potential for some blood cancers...
The University of Texas MD Anderson Cancer Center will share novel research findings, cancer prevention tips and advances driven by the institution...
Prospective, randomized trial will compare surgery, active surveillance; evaluate quality of life
____________________________________...